These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 27813209)

  • 41. Critical overview: adverse cutaneous reactions to psychotropic medications.
    Kimyai-Asadi A; Harris JC; Nousari HC
    J Clin Psychiatry; 1999 Oct; 60(10):714-25; quiz 726. PubMed ID: 10549695
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subacute cutaneous lupus erythematosus associated with radioiodine treatment.
    Abbott RA; May K; Motley RJ
    Clin Exp Dermatol; 2012 Oct; 37(7):753-4. PubMed ID: 22369225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydroxyurea-induced melanonychia concomitant with a dermatomyositis-like eruption.
    Oh ST; Lee DW; Lee JY; Cho BK
    J Am Acad Dermatol; 2003 Aug; 49(2):339-41. PubMed ID: 12894095
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus.
    Parodi A; Rivara G; Guarrera M
    JAMA; 1992 Jul; 268(1):51-2. PubMed ID: 1535107
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug-induced subacute cutaneous lupus erythematosus associated with doxorubicin.
    Chen JK; Chen TS; Lim P; Iqbal M
    J Am Acad Dermatol; 2012 Dec; 67(6):e273-5. PubMed ID: 23158635
    [No Abstract]   [Full Text] [Related]  

  • 46. Omeprazole-induced subacute cutaneous lupus erythematosus.
    Mankia SK; Rytina E; Burrows NP
    Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
    [No Abstract]   [Full Text] [Related]  

  • 47. Cutaneous manifestations of long-term hydroxyurea therapy.
    Kelly RI; Bull RH; Marsden A
    Australas J Dermatol; 1994; 35(2):61-4. PubMed ID: 7702489
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Widespread Scaly Eruption in a Patient With Multiple Comorbidities.
    Jones EK; Mingioni N; Lee JB
    JAMA; 2015 Oct; 314(16):1740-1. PubMed ID: 26505598
    [No Abstract]   [Full Text] [Related]  

  • 49. Cutaneous drug eruptions associated with the use of biologies and cutaneous drug eruptions mimicking specific skin diseases.
    Seneschal J; Milpied B; Taieb A
    Chem Immunol Allergy; 2012; 97():203-16. PubMed ID: 22613864
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
    Callen JP
    JAMA Dermatol; 2013 Sep; 149(9):1075-6. PubMed ID: 23842706
    [No Abstract]   [Full Text] [Related]  

  • 51. Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions.
    Marzano AV; Ramoni S; Del Papa N; Barbareschi M; Alessi E
    Lupus; 2008 Apr; 17(4):329-31. PubMed ID: 18413415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Subacute-cutaneous lupus erythematosus induced by Simvastatin.
    Rüger RD; Simon JC; Treudler R
    J Dtsch Dermatol Ges; 2011 Jan; 9(1):54-5. PubMed ID: 21040470
    [No Abstract]   [Full Text] [Related]  

  • 53. Proton pump inhibitors and subacute cutaneous lupus erythematosus: an under-recognized phenomenon?
    Cookson H; Walsh S
    Br J Dermatol; 2014 Feb; 170(2):235. PubMed ID: 24547716
    [No Abstract]   [Full Text] [Related]  

  • 54. Subacute cutaneous lupus erythematosus associated with terbinafine.
    Kasperkiewicz M; Anemüller W; Angelova-Fischer I; Rose C; Zillikens D; Fischer TW
    Clin Exp Dermatol; 2009 Oct; 34(7):e403-4. PubMed ID: 19549237
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic hydroxyurea-induced dermatomyositis-like eruption with severe dermal elastosis.
    Vélez A; López-Rubio F; Moreno JC
    Clin Exp Dermatol; 1998 Mar; 23(2):94-5. PubMed ID: 9692318
    [No Abstract]   [Full Text] [Related]  

  • 56. Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus.
    McNamara K; Hughes OB; Strowd LC
    Clin Dermatol; 2020; 38(6):641-647. PubMed ID: 33341198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leg ulcers in patients treated with hydroxyurea for myeloproliferative disorders: what is the trigger?
    Weinlich G; Fritsch P
    Br J Dermatol; 1999 Jul; 141(1):171-2. PubMed ID: 10417546
    [No Abstract]   [Full Text] [Related]  

  • 58. Subacute cutaneous lupus erythematosus presenting in twins.
    Montuno MA; Church AA; Schoch JJ; Andrews ID
    Pediatr Dermatol; 2018 Mar; 35(2):e128-e131. PubMed ID: 29436018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 60. Terbinafine as a cause of cutaneous lupus erythematosus.
    McKellar G; Porter D; Burden D
    Rheumatology (Oxford); 2004 Feb; 43(2):249. PubMed ID: 14739471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.